Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Adiponectin in chronic heart failure: influence of diabetes and genetic variants

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A totally new system is needed for drug research and development

    Research output: Contribution to journalLetterResearchpeer-review

  2. Patients not patents: Drug research and development as a public enterprise

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Prediction of coronary heart disease or heart failure using high-sensitivity cardiac troponin T: a pilot study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Anti-inflammatory effects of exercise: role in diabetes and cardiovascular disease

    Research output: Contribution to journalReviewResearchpeer-review

  5. Familial hypercholesterolaemia: cholesterol efflux and coronary disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Low serum adiponectin is associated with the metabolic syndrome and adds to cardiovascular risk in individuals with type 1 diabetes without nephropathy

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  2. The effect of liraglutide on natriuretic peptides and copeptin in heart failure patients

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  3. High Intrarenal Lactate Production Inhibits the Renal Pseudohypoxic Response to Acutely Induced Hypoxia in Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Association of Changes in Inflammation with Changes in Glycemia, Insulin Resistance and Secretion: a DIRECT study based on KORA

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Serge Masson
  • Francesca Gori
  • Roberto Latini
  • Valentina Milani
  • Allan Flyvbjerg
  • Jan Frystyk
  • Luisa Crociati
  • Silvia Pietri
  • Tarcisio Vago
  • Simona Barlera
  • Aldo P Maggioni
  • Gianni Tognoni
  • Luigi Tavazzi
  • Torbjørn Omland
  • Maria Grazia Franzosi
  • GISSI-HF Investigators
View graph of relations

BACKGROUND: We hypothesized that, besides type 2 diabetes (T2D) and body mass index (BMI), circulating adiponectin concentration would be associated with variants of the ADIPOQ gene in patients with chronic heart failure (CHF). We also assessed the influence of these confounders on the prognostic value of adiponectin.

METHODS: Plasma adiponectin was measured at entry and after 3 months in approximately 1200 patients with CHF enrolled in the GISSI-HF trial. Four common single-nucleotide polymorphisms (SNPs) spanning the ADIPOQ gene were studied: rs17300539 (-11391G→A), rs266729 (-11377C→G), rs2241766 (+45T→G) and rs1501299 (+276G→T). Associations with clinical characteristics and mortality were evaluated in patients with or without T2D.

RESULTS: Adiponectin concentrations were negatively related to BMI, higher in women and older persons, but lower in patients with diabetes. T-allele carriers for rs1501299 and A-allele carriers for rs17300539 had significantly elevated adiponectin concentrations. Irrespective of diabetes, baseline plasma adiponectin was independently associated with mortality (adjusted HR [95%CI] per 1 SD increase in adiponectin concentration = 1·24[1·12-1·37], P < 0·0001) and improved prognostic discrimination beyond clinical risk factors (integrated discrimination improvement, P = 0·005). Patients with increasing adiponectin concentration over 3 months had worse outcome than those with stable levels (unadjusted HR = 1·46[1·09-1·96], P = 0·01); this relation was attenuated by the genetic variants examined and by robust confounders like age, diabetes, BMI or NT-proBNP (adjusted HR = 1·37[0·97-1·94], P = 0·075).

CONCLUSIONS: Although diabetes and genetic variants at the ADIPOQ gene influence the circulating levels of adiponectin in CHF, higher plasma adipokine levels, but not genetic variants, are consistently associated with a poor prognosis.

Original languageEnglish
JournalEuropean Journal of Clinical Investigation
Volume41
Issue number12
Pages (from-to)1330-8
Number of pages9
ISSN0014-2972
DOIs
Publication statusPublished - Dec 2011
Externally publishedYes

    Research areas

  • Adiponectin, Age Factors, Aged, Aged, 80 and over, Body Mass Index, Diabetes Mellitus, Type 2, Female, Genetic Predisposition to Disease, Heart Failure, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Risk Factors, Sex Factors, Survival Analysis, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't

ID: 51725351